49
Participants
Start Date
March 31, 2015
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
IGIV-C
An IV dose of 2 g/kg of IGIV-C was administered over 2 consecutive days at a dose of 1 g/kg per day.
Jahn Ferenc Del-Pesti Korhaz, Budapest
Pest Megyei Flor Ferenc Korhaz, Kistarcsa
UZ Leuven, Leuven
University of Szeged, Faculty of Medicine, Szeged
Zala Megyei Korhaz, Zalaegerszeg
AZ St Lucas Gent, Ghent
East Tallinn Central Hospital, Tallinn
Vseobecna fakultni nemocnice v Praze, Prague
Hôpital de la Timone, Marseille
Institutul Clinic Fundeni, Bucharest
CHU de Toulouse - Hôpital Purpan, Toulouse
Hôpital Albert Michallon, Grenoble
Hopital Roger Salengro, Lille
Hôpital Hautepierre Strasbourg, Strasbourg
Hopital Neurologique Pierre Wertheimer, Bron
Fakultni nemocnice Ostrava, Neurologická klinika, Ostrava
Saint-Petersburg State Budgetary Institution of Healthcare. City Multi-field Hospital # 2, Saint Petersburg
"State Budgetary Institution of Healthcare Samara Regional Clinical Hospital. V.D.Seredavin", Samara
State Budgetary Institution of Healthcare of Nizhniy Novgorod region. Nizhniy Novgorod Regional Clinical Hospital named after N.A.Semashko, Nizhny Novgorod
Hospital Italiano, Buenos Aires
Hospital General de Agudos Dr. J. M., Buenos Aires
Hospital Cordoba, Córdoba
University of Alberta Hospital, Edmonton
London Health Sciences Centre, London
University Health Network (UHN) - Toronto General Hospital, Toronto
Fakultni nemocnice Brno, Neurologicka klinika, Brno
Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház, Nyíregyháza
Uniwersyteckie Centrum Kliniczne, Gdansk
Groote Schuur Hospital,, Cape Town
Riga East Clinical University Hospital, Riga
Spitalul Clinic Judetean de Urgenta Targu-Mures, Târgu Mureş
Lead Sponsor
Grifols Therapeutics LLC
INDUSTRY